Trial Details

TERMINATED
Basic Information
Clinical ID c1020
Identifier NCT04478825
Trial Title Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: BBT-401-1S
Participant Information
Sponsor Bridge Biotherapeutics, Inc.
City Tauranga
Country/Region New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2021-06-01
Primary Completion Date 2021-08-04
Completion Date 2021-08-24